ABSTRACT A computer technique (cosinor analysis) has been used to evaluate circadian rhythms in airway calibre in normals and asthmatics. Two hundred and twenty-one normal subjects recorded peak expiratory flow rate (PEFR) at home four times a day for seven days. Rhythm detection was statistically significant in 145 of them (65-6%) who showed a mean amplitude of 8-3% of individual mean PEFR (± SD 5 2%). Amplitude was independent of age, sex, atopy, family history of asthma, and smoking habit. Fifteen of them were also studied three times a day for five days in the laboratory with flow-volume loops. Eleven showed significant PEFR rhythms at home. No single measurement from the flow-volume loop showed periodicity in as many of them but rhythms were now also detected in the other four normal subjects in some components of the loop. Fifty-six asthma patients were studied with a similar protocol of PEFR measurement and compared with the 145 rhythmic normal subjects. These studies have provided relatively little information on the characteristics of the normal rhythm in airway calibre, principally because of the small numbers of subjects recruited. In particular, there is very little information available on the amplitude and phase of the PEFR rhythm in normal subjects. We have, therefore, studied the PEFR rhythm in larger numbers of normal subjects. We
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PEFR was measured for seven consecutive days: on waking, on leaving home for work, on coming home in the evening, and at bedtime. At weekends the middle two sets of readings were performed at the same times as had been necessary during the working week. Retired subjects took these readings one hour after waking and at 1800. On each occasion PEFR was measured three times with a peak flow gauge (Airmed) with a 30 second rest between attempts. All three readings were subsequently analysed individually in the computer programme. Recordings were made in the sitting position and the scale was read to the nearest 5 I min-1, the reading accuracy of the instrument. Subjects documented all three readings and the exact time of measurement on a diary chart. STUDY 2 Fifteen of the subjects recruited to study 1 were also able to attend for laboratory studies. For five consecutive days (Monday to Friday) they recorded flow-volume loops" at 0930, 1200, and 1730. Loops were recorded with an Ohio 800 spirometer linked by an Ohio flow-volume converter to a Prime 300 computer which displayed the loops and recorded measurements from it. Three attempts were made on each occasion in the sitting position, with a 30 second rest between attempts. STUDY 
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A similar protocol of PEFR measurements to that described in study 1 was carried out for seven days in asthma patients. Criteria for selection of these patients were that they gave a history of variable wheezy breathlessness over short periods of time with improvement after treatment or spontaneously, their sputum production (if any) was insufficient to satisfy the MRC criteria for chronic bronchitis,18 and they showed a >20% improvement in PEFR or forced expiratory volume in one second (FEV1) after inhaled or oral bronchodilator drugs or a > 50 % improvement in PEFR over the course of their hospital admission. They were either studied during convalescence from acute asthma in hospital or at home, immediately after discharge from hospital.
ANALYSIS
In all three studies data were analysed by the cosinor method of Halberg et al.19 20 This technique uses a least squares method to test the goodness of fit of the raw data to a sinusoidal waveform. The function: None of the other factors studied in the questionnaire appeared to influence amplitude in these 145 subjects with significant rhythms. Thirty were currently smoking, 37 had previously been regular smokers, and 78 had never smoked. Amplitudes in these three categories were 7-8%, 8-6%, and 822% respectively and were not significantly different from each other. Thirty-nine had a family history of asthma in a blood relative but their mean amplitude (7-7%) was not significantly different from the remaining 106 subjects (mean 8 4%) without any family history. Twenty-eight had some history ofatopy without asthma but their amplitudes (mean 7 7%) were not significantly different from 117 subjects with no history of atopy (mean 8 3 %). Table 2 shows the number of subjects with significant rhythmicity in each test. For comparison the mean amplitude and acrophase quoted for each test are those of the whole group, even though some subjects did not achieve significant rhythmicity in a given test. The mean acrophase for PEFR at home in these 15 normal subjects (1533) can be compared with acrophases ranging from 0956-1531 in different components of the flow-volume loop. Figure 1 compares the phases of the PEFR rhythms of the 56 asthma patients with the 145 normal subjects in whom a significant rhythm was demonstrated in study 1; results are shown as a histogram of the number of subjects whose acrophase occurred in each hour of the day. The distribution of phase was similar between normal subjects and asthma patients so that the majority had an acrophase between 1400 and 2200 hours. Figure 2 uses the same format to illustrate the distribution of the estimated acrophases intheremaining 76 normal subjects in whom rhythmicity could not be demonstrated at a statistically significant level in study 1. The distribution of these estimates for phase nevertheless appeared similar to that shown in fig 1 with the majority of these 76 subjects having an acrophase between 1300 and 1700. Figure 3 illustrates the normal and asthmatic PEFR rhythms as a cosinor summary. 20 The mean rhythms of the 145 normal subjects with significant rhythmicity and the 56 asthma patients are shown as vectors with their length proportional to their amplitude and their angle indicating their phase (time of the acrophase or highest point in the cycle). The error ellipses around the ends of these vectors show the 95 % confidence limits for amplitude and phase. The dotted lines indicate overlap of the ellipses for phase, which is not therefore significantly different between normal subjects and asthma patients. The arrows indicate the 95% confidence limits for the 22 24 Fig bathyphase (lowest point in the cycle) for the normal and asthmatic rhythms, which ranged between 0240 and 0515.
Discussion
Our results show that a low amplitude circadian rhythm in airway calibre can be demonstrated in the majority of normal subjects (145 of 221 or 65 -6 %) by measuring PEFR with a very simple instrument. Moreover, in the remaining 76 normal subjects, in whom rhythm detection did not achieve statistical significance, the computed estimates of the phase of their rhythms nevertheless showed a very similar distribution (fig 2) to that seen in the subjects with significant rhythmicity (fig 1) . This similarity would not have been expected if results in these 76 subjects were an artefact, from biological noise alone, without any underlying periodicity. We, therefore, suggest that all normal subjects have a circadian rhythm in PEFR but, in the minority of those studied, amplitude was too low for rhythm detection with the peak flow gauge.
Study 2 compared the performance of the peak flow gauge at home with laboratory measurement of the flow-volume loop in rhythm detection. Because subjects could only be studied over about half their waking day in the laboratory, use of more sophisticated apparatus in study 2 16 .00 hours, and at bedtime would be a convenient protocol of measurements which would give a good approximation of the amplitude of the PEFR rhythm.
No factors were found which influenced amplitude in the PEFR rhythm of normal subjects in study 1. There was some indication of a possible trend towards increasing amplitude with age but this was only significant in the 61-70 year age group. We suspect this was an artefact, however, since numbers were smaller in the older age groups and we were less confident of their normality since predicted normal PEFR could only be estimated by extrapolation of Cotes' data15 in the over 60s. Thus we found a fairly narrow range for amplitude in normal subjects. The 56 asthma patients recruited to study 3 were comparable to the 145 rhythmic normal subjects for age and sex and the phases of their rhythms were strikingly similar. The asthmatic rhythm was distinguished only by its greater amplitude. The phenomenon of nocturnal and early morning asthma, therefore, probably results from amplification of a normal circadian rhythm in airway calibre by the abnormally labile asthmatic airways.
We conclude that measurement of the amplitude of the PEFR rhythm is a valuable clinical tool in the diagnosis and management of asthma. Since it appears to relate to bronchial lability it has particular value in detection of unstable asthma as previously reported in its association with sudden asthma death.2 3 In addition to increasing the mean PEFR, reduction of the amplitude of the PEFR rhythm should also be an objective of treatment. Measurement of PEFR amplitude, therefore, merits consideration in trials of new drugs for asthma. 
